|
| 產(chǎn)地 | 進(jìn)口、國產(chǎn) |
| 品牌 | 上海莼試 |
| 保存條件 | Store at -20 °C |
| 貨號(hào) | CS11730 |
| 應(yīng)用范圍 | WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 Flow-Cyt=1:100-500 IF=1:100-500 |
| CAS編號(hào) | |
| 抗體名 | Anti-TIE2/CD202b |
| 克隆性 | |
| 靶點(diǎn) | 詳見說明書 |
| 適應(yīng)物種 | 詳見說明書 |
| 形態(tài) | 詳見說明書 |
| 宿主 | 詳見說明書 |
| 亞型 | IgG |
| 標(biāo)識(shí)物 | 詳見說明書 |
| 濃度 | 1mg/1ml% |
| 免疫原 | KLH conjugated synthetic peptide derived from human Tie2 |
中文名稱 生成素受體2抗體規(guī)格
英文名稱 Anti-TIE2/CD202b
別 名 Tie-2; Tie2; Tek; Angiopoietin-1 receptor; Tyrosine-protein kinase receptor TIE-2; hTIE2; Tyrosine-protein kinase receptor TEK; Tunica interna endothelial cell kinase; p140 TEK; Angiopoietin 1 receptor; CD202b; CD202b antigen; Endothelial tyrosine kinase; Endothelium specific receptor tyrosine kinase 2; hTIE 2; Hyk; Soluble TIE2 variant 1; Soluble TIE2 variant 2; tek tyrosine kinase; TEK tyrosine kinase endothelial; tek tyrosine kinase, endothelial; TIE 2; TIE2_HUMAN; Tunica interna endothelial cell kinase; Tyrosine kinase with Ig and EGF homology domains 2; Tyrosine protein kinase receptor TEK; Tyrosine protein kinase receptor TIE 2; Tyrosine-protein kinase receptor TIE-2; Venous malformations multiple cutaneous and mucosal; VMCM 1; VMCM; VMCM1; CD202b.
產(chǎn)品屬性：
生成素受體2抗體規(guī)格 濃 度 1mg/1ml
規(guī) 格 0.1ml/100μg 0.2ml/200μg
抗體來源 Rabbit
克隆類型 polyclonal
交叉反應(yīng) Human, Mouse, Rat, Pig, Cow, Horse
產(chǎn)品類型 一抗
研究領(lǐng)域 心 信號(hào)轉(zhuǎn)導(dǎo) 干細(xì)胞 生長因子和激素 激酶和磷酸酶
蛋白分子量 predicted molecular weight: 124kDa
性 狀 Lyophilized or Liquid
免 疫 原 KLH conjugated synthetic peptide derived from human Tie2
亞 型 IgG
純化方法 affinity purified by Protein A
儲(chǔ) 存 液 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide
生成素受體2抗體規(guī)格 產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 Flow-Cyt=1:100-500 IF=1:100-500
（石蠟切片需做抗原修復(fù)）
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
保存條件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
產(chǎn)品介紹 The TEK receptor tyrosine kinase is expressed almost exclusively in endothelial cells in mice, rats, and humans. This receptor possesses a unique extracellular domain containing 2 immunoglobulin-like loops separated by 3 epidermal growth factor-like repeats that are connected to 3 fibronectin type III-like repeats. The ligand for the receptor is angiopoietin-1. Defects in TEK are associated with inherited venous malformations; the TEK signaling pathway appears to be critical for endothelial cell-smooth muscle cell communication in venous morphogenesis.TEK is closely related to the TIE receptor tyrosine kinase.
Function : Tyrosine-protein kinase that acts as cell-surface receptor for ANGPT1, ANGPT2 and ANGPT4 and regulates angiogenesis, endothelial cell survival, proliferation, migration, adhesion and cell spreading, reorganization of the actin cytoskeleton, but also maintenance of vascular quiescence. Has anti-inflammatory effects by preventing the leakage of proinflammatory plasma proteins and leukocytes from blood vessels. Required for normal angiogenesis and heart development during embryogenesis. Required for post-natal hematopoiesis. After birth, activates or inhibits angiogenesis, depending on the context. Inhibits angiogenesis and promotes vascular stability in quiescent vessels, where endothelial cells have tight contacts. In quiescent vessels, ANGPT1 oligomers recruit TEK to cell-cell contacts, forming complexes with TEK molecules from adjoining cells, and this leads to preferential activation of phosphatidylinositol 3-kinase and the AKT1 signaling cascades. In migrating endothelial cells that lack cell-cell adhesions, ANGT1 recruits TEK to contacts with the extracellular matrix, leading to the formation of focal adhesion complexes, activation of PTK2/FAK and of the downstream kinases MAPK1/ERK2 and MAPK3/ERK1, and ultimately to the stimulation of sprouting angiogenesis. ANGPT1 signaling triggers receptor dimerization and autophosphorylation at specific tyrosine residues that then serve as binding sites for scaffold proteins and effectors. Signaling is modulated by ANGPT2 that has lower affinity for TEK, can promote TEK autophosphorylation in the absence of ANGPT1, but inhibits ANGPT1-mediated signaling by competing for the same binding site. Signaling is also modulated by formation of heterodimers with TIE1, and by proteolytic processing that gives rise to a soluble TEK extracellular domain. The soluble extracellular domain modulates signaling by functioning as decoy receptor for angiopoietins. TEK phosphorylates DOK2, GRB7, GRB14, PIK3R1; SHC1 and TIE1.
Subunit : Homodimer. Heterodimer with TIE1. Interacts with ANGPT1, ANGPT2 and ANGPT4. At cell-cell contacts in quiescent cells, forms a signaling complex composed of ANGPT1 plus TEK molecules from two adjoining cells. In the absence of endothelial cell-cell contacts, interaction with ANGPT1 mediates contacts with the extracellular matrix. Interacts with PTPRB; this promotes endothelial cell-cell adhesion. Interacts with DOK2, GRB2, GRB7, GRB14, PIK3R1 and PTPN11/SHP2. Colocalizes with DOK2 at contacts with the extracellular matrix in migrating cells. Interacts (tyrosine phosphorylated) with TNIP2. Interacts (tyrosine phosphorylated) with SHC1 (via SH2 domain).
Subcellular Location : Cell membrane; Single-pass type I membrane protein. Cell junction. Cell junction, focal adhesion. Cytoplasm, cytoskeleton. Secreted.
Tissue Specificity : Detected in umbilical vein endothelial cells. Proteolytic processing gives rise to a soluble extracellular domain that is detected in blood plasma (at protein level). Predominantly expressed in endothelial cells and their progenitors, the angioblasts. Has been directly found in placenta and lung, with a lower level in umbilical vein endothelial cells, brain and kidney.
Post-translational modifications : Proteolytic processing leads to the shedding of the extracellular domain (soluble TIE-2 alias sTIE-2).
Autophosphorylated on tyrosine residues in response to ligand binding. Autophosphorylation occurs in trans, i.e. one subunit of the dimeric receptor phosphorylates tyrosine residues on the other subunit. Autophosphorylation occurs in a sequential manner, where Tyr-992 in the kinase activation loop is phosphorylated first, followed by autophosphorylation at Tyr-1108 and at additional tyrosine residues. ANGPT1-induced phosphorylation is impaired during hypoxia, due to increased expression of ANGPT2. Phosphorylation is important for interaction with GRB14, PIK3R1 and PTPN11. Phosphorylation at Tyr-1102 is important for interaction with SHC1, GRB2 and GRB7. Phosphorylation at Tyr-1108 is important for interaction with DOK2 and for coupling to downstream signal transduction pathways in endothelial cells. Dephosphorylated by PTPRB.
Ubiquitinated. The phosphorylated receptor is ubiquitinated and internalized, leading to its degradation.
DISEASE : Defects in TEK are a cause of dominantly inherited venous malformations (VMCM) [MIM:600195]; an error of vascular morphogenesis characterized by dilated, serpiginous channels.
Note=May play a role in a range of diseases with a vascular component, including neovascularization of tumors, psoriasis and inflammation.
Similarity : Belongs to the protein kinase superfamily. Tyr protein kinase family. Tie subfamily.
Contains 3 EGF-like domains.
Contains 3 fibronectin type-III domains.
Contains 2 Ig-like C2-type (immunoglobulin-like)domains.
Contains 1 protein kinase domain.
Database links : UniProtKB/Swiss-Prot: Q02763.2
Tie2 是內(nèi)皮特異性的酪氨酸激酶型受體, 主要表達(dá)在肺內(nèi)皮以及卵泡、創(chuàng)口肉芽組織等內(nèi)皮. 在發(fā)育中起重要的.
實(shí)驗(yàn)流程：
全、新、優(yōu)、品、好四大特點(diǎn)：
生成素受體2抗體規(guī)格 全：公司提供上萬種產(chǎn)品，涵蓋了生物試劑，elisa試劑盒，標(biāo)準(zhǔn)品，培養(yǎng)基，原裝耗材，抗體、培養(yǎng)基、ATCC細(xì)胞等，基本上各種科研所需產(chǎn)品在我司都能找到。
新：產(chǎn)品更新速度較快，基本上每周都有新產(chǎn)品出現(xiàn)。
優(yōu)：產(chǎn)品質(zhì)量好，投訴比較少。
好：我公司具有優(yōu)質(zhì)的技術(shù)團(tuán)隊(duì)，產(chǎn)品一旦售出，實(shí)驗(yàn)過程中遇到困難可提供在線技術(shù)咨詢。使您使用產(chǎn)品時(shí)沒有任何的后顧之憂。
技術(shù)外包服務(wù):
★生成素受體2抗體規(guī)格 分子生物學(xué)：質(zhì)粒抽提、PCR、Q-PCR、RT-PCR、分子生物學(xué)：基因合成、引物合成、基因測(cè)序、載體構(gòu)建等
★蛋白工程：原核、哺乳動(dòng)物蛋白表達(dá)系統(tǒng)等
★病毒包裝：腺病毒、慢病毒等
★抗體工程：磁珠分選、病理染色、WB、ELISA、IP、IF、IHC、FACS、Confocal等等
★細(xì)胞工程：細(xì)胞表型分析(凋亡、增殖、周期、遷移、侵襲、修復(fù)、克隆形成)、細(xì)胞培養(yǎng)、細(xì)胞膜制備、穩(wěn)定細(xì)胞株構(gòu)建、細(xì)胞RNAi技術(shù)等等。
正在熱銷的相關(guān)產(chǎn)品：
Anti-Plectin/FITC 熒光素標(biāo)記網(wǎng)蛋白抗體IgGMulti-class antibodies規(guī)格： 0.2ml
Rat IgG (親和純化) 大鼠IgGMulti-class antibodies規(guī)格： 1mg
高遷移率族蛋白-1抗體 Anti-HMGB1 0.1ml
Goat Anti-Guinea pig IgG 羊抗豚鼠IgG 1mg
FGF8 英文名稱： 成纖維細(xì)胞生長因子8抗體 0.1ml
Rhesus antibody Rh Phospho-RelB(Ser573) 磷酸化核轉(zhuǎn)錄因子NFKB-RelB蛋白抗體 規(guī)格 0.1ml
Rat IgG (親和純化) 大鼠IgGMulti-class antibodies規(guī)格： 1mg
HSP-90 Alpha(Heat Shock Protein 90 Alpha ) 熱休克蛋白90α抗體Multi-class antibodies規(guī)格： 0.5mg
Anti-phospho-c-Abl(Tyr204) 磷酸化非受體酪氨酸激酶c-Abl抗體Multi-class antibodies規(guī)格： 0.1ml
Rhesus antibody Rh phospho-CHEK1 (Ser280) 磷酸化細(xì)胞周期檢測(cè)點(diǎn)激酶1抗體 規(guī)格 0.1ml
兔抗豬IgG血清 0.5ml 國產(chǎn)
Wnt11 英文名稱： 信號(hào)通路Wnt11抗體 0.1ml
Phospho-Doublecortin (Ser128) 英文名稱： 磷酸化雙皮質(zhì)素抗體 0.1ml
Anti-phospho-c-Abl(Tyr204) 磷酸化非受體酪氨酸激酶c-Abl抗體Multi-class antibodies規(guī)格： 0.1ml
Anti-Zyxin/FITC 熒光素標(biāo)記斑聯(lián)蛋白抗體IgGMulti-class antibodies規(guī)格： 0.2ml
DCX(Doublecortin) 雙皮質(zhì)素抗原Multi-class antibodies規(guī)格： 0.5mg
膜粘連蛋白 V抗體 Anti-Annexin V 0.1ml
ZBTB48 英文名稱： 鋅指蛋白855抗體 0.2ml
DACT1 英文名稱： 新基因3蛋白抗體 0.2ml
Rhesus antibody Rh phospho-ERK1/MAPK-1/2(Thr183/185) 磷酸化原活化蛋白激酶1/2抗體 規(guī)格 0.1ml
DCX(Doublecortin) 雙皮質(zhì)素抗原Multi-class antibodies規(guī)格： 0.5mg
人白介素13(IL-13)ELISA 試劑盒 96T/48T 試劑盒 組裝/原裝
兔子硫酸軟骨素(CS)免疫試劑盒 Rabbit chondroitin sulfate,CS ELISA Kit
神經(jīng)細(xì)胞粘著分子(CAM)ELISA試劑盒 ，英文名： CAM ELISA Kit
PorcineImmunoglobulinE,IgEELISA試劑盒豬免疫球蛋白E(IgE)ELISA試劑盒規(guī)格：96T/48T
humanADAMmetallopeptidasewiththrombospondiype1motif4,ADAMTS4ELISA試劑盒人ADAM金屬肽酶含血小板反應(yīng)蛋白1基元4(ADAMTS4)ELISA試劑盒規(guī)格：96T/48T
HumanAi-Saccharomycescerevisiaeaibody,ASCAELISAKit人抗釀酒酵母抗體(ASCA)ELISA試劑盒規(guī)格：96T/48T
大鼠酸激酶M2型同工酶(M2-PK)ELISA試劑盒 ，英文名： M2-PK ELISA Kit
Mouse alpha L fucosidase (AFU) ELISA Kit 小鼠αL巖藻糖苷酶(AFU)ELISA試劑盒
ELISA 小鼠上皮中性粒細(xì)胞活化肽-78(mouse ENA-78) 48T/96T 進(jìn)口分裝
CLIAKitforKLK11(HumanKallikrein11)ELISAKit人激肽釋放酶11規(guī)格：48T/96T
通用型腸桿菌(EerobacteriaceaSTX2)試劑盒20次
ELISAKitHIS大鼠組胺規(guī)格：48T/96T
生成素受體2抗體規(guī)格 大鼠胃動(dòng)蛋白2(GKN2)ELISA試劑盒 ，英文名： GKN2 ELISA Kit
Mouse aquaporin 3 (AQP-3) ELISA Kit 小鼠水通道蛋白3(AQP-3)ELISA試劑盒
MouseomeinELISAKit 小鼠網(wǎng)膜素(omein)ELISA試劑盒 96T/48T 進(jìn)口分裝
CLIAKitforhs-CRP(MousehighsensitivityC-ReactiveProtein)ELISAKit小鼠超敏C反應(yīng)蛋白規(guī)格：48T/96T
細(xì)胞NADP依賴性甘油-3-磷酸脫氫酶(NADP-Glyceraldehyde-3-PhosphateDehydrogenase;NADP-GAPDH)活性光譜法定量檢測(cè)試劑盒20次
ELISAKitβ-TG大鼠β血小板球蛋白/β環(huán)蛋白規(guī)格：48T/96T
|
|
|
|
|
